Announced
Financials
Tags
Private
Cross Border
Majority
Private Equity
glass bottles
Containers and Packaging
France
Friendly
Single Bidder
Acquisition
Pending
Synopsis
PAI Partners, a private equity firm, agreed to acquire SGD Pharma, a provider of production and decoration of glass bottles, from China Jianyin Investment, a Chinese investment company, for c.$1bn. "By investing in cutting-edge manufacturing technologies, in taking the lead on sustainability and through constantly improving the service level it offers to its clients, the SGD Pharma teams have built a solid platform for performance and growth under JIC’s ownership. We are now thrilled to contemplate the next stage of SGD Pharma’s development with PAI – an experienced and supportive partner," Christophe Nicoli, SGD Pharma CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.